Policy / Pricing Trump revives pharma tariffs with 100% charges, but leaves loopholes pharminent April 3, 2026
Policy / Pricing Trump Hits Drugmakers With 100% Tariff but Carve-outs Soften the Blow pharminent April 3, 2026
Policy / Pricing Rare Disease Leaders Call for Regulatory Clarity as FDA Balances Urgency With Rigor pharminent April 2, 2026
Policy / Pricing Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling pharminent April 2, 2026
Policy / Pricing A ‘hijacked plane’: CDC, under RFK Jr.’s influence, trades science for dogma pharminent April 1, 2026
